REVUMENIB for Acute lymphocytic leukaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 13 adverse event reports in the FDA FAERS database where REVUMENIB was used for Acute lymphocytic leukaemia.

Most Reported Side Effects for REVUMENIB

Side Effect	Reports	%	Deaths	Hosp.
Off label use	57	15.4%	2	2
Platelet count decreased	50	13.5%	2	19
Nausea	49	13.2%	1	13
Product dose omission issue	40	10.8%	2	17
Death	38	10.2%	38	6
Vomiting	26	7.0%	1	9
Fatigue	24	6.5%	0	11
Pyrexia	22	5.9%	3	14
Differentiation syndrome	16	4.3%	3	4
Haemoglobin decreased	16	4.3%	2	8
White blood cell count decreased	16	4.3%	0	5
Diarrhoea	15	4.0%	0	4
Disease progression	15	4.0%	4	4
Drug ineffective	15	4.0%	2	4
Neutrophil count decreased	15	4.0%	1	2